Vienna, Austria

Stefan Naschberger

This inventor holds 1 USPTO granted patent. Top assignee: Polymun Scientific Immunbiologische Forschung Gmbh. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Naschberger

Introduction

Stefan Naschberger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biochemistry, particularly in the area of protein manufacturing. His work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Stefan Naschberger holds a patent for a "Method for the manufacture of recombinant trypsin." This invention relates to a method for the manufacture and purification of recombinant trypsinogen and trypsin in yeast, utilizing high yield expression vectors with and without secretion leader sequences. The invention also includes an improved method and apparatus for carrying out protein refolding, which is particularly useful for processing trypsinogen that has accumulated intracellularly in the form of inclusion bodies. He has 1 patent to his name.

Career Highlights

Stefan is associated with Polymun Scientific Immunbiologische Forschung GmbH, where he continues to advance his research and development efforts. His work at this company has allowed him to explore innovative solutions in the field of immunobiological research.

Collaborations

Stefan has collaborated with notable colleagues, including Robert Weik and Hubertus Hohenblum. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Stefan Naschberger's contributions to the field of biochemistry through his innovative methods for protein manufacturing highlight his role as a significant inventor. His work continues to influence the biotechnology sector and offers promising advancements for future applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…